Quantcast
Home (page 3)

Tag Archives: FDA

J&J unit settles state Risperdal claims for $181M

Johnson & Johnson has agreed to pay a record $181 million to settle claims brought by New York and 36 other states that the company’s Janssen Pharmaceuticals unit improperly marketed Risperdal and other anti-psychotic drugs for “off-label” uses.

Read More »

Medtronic bone graft suit isn’t preempted, says trial court

Federal law does not preempt a product liability suit brought by a woman who claimed she suffered injuries as a consequence of Medtronic’s promotion of a bone graft device for “off-label” uses, a California trial court has ruled in denying ...

Read More »

Benchmarks: Woman blinded by colored contacts faces FDA preemption

Apparently, there is no end to what you can buy at a dollar store. One South Carolina woman found to her ever-lasting regret that dollar store shoppers can actually buy prescription colored contact lenses – without the bother of a ...

Read More »